2026 Spring Mentorship Mingle
PeDRA Biostatistician Amy Buros Stein, PhD, provides a detailed presentation on how to prepare for your first consultation with…
My First SID Experience: Seeing Research Come to Life
June 2, 2026 – Before attending the Society for Investigative Dermatology (SID) Annual Meeting for the first time, I…
Pediatric Atopic Dermatitis: New Guidelines, New Treatments, New Questions
In this episode, host Jenn Dawson talks with Dr. Dawn Davis, Dr. Amy Paller, and Dr. Larry Eichenfield about…
2026 Society for Investigative Dermatology (SID) Annual Meeting Coverage
PeDRA was proud to be part of the 2026 Society for Investigative Dermatology (SID) Annual Meeting. From cutting-edge research presentations…
Heroes for Hallie Grace: Turning Grief into Action
In this episode, host Jenn Dawson speaks with Anne Davis, Psy.D., clinical psychologist, grief and trauma specialist, and mother…
Research In Action: Advancing Care for Epidermolysis Bullosa
The PeDRA Epidermolysis Bullosa Educational Series is a virtual program designed to explore recent scientific advances, emerging treatments, patient…
Mosaic STIM1 Variant Associated with Epidermal Nevus
Luo, Angela, et al. British Journal of Dermatology (2026).
STARC Spotlight: Skin Toxicities & Tumors in Pediatric Cancer Care
Skin reactions during pediatric cancer treatment can be painful, stigmatizing, and sometimes threaten a child’s ability to stay on therapy. In this episode of PeDRA Pearls, Dr. Christina Boull and Dr. Rebecca Levy discuss PeDRA’s Skin Tumors and Reactions to Cancer Therapies (STARC) Focused Study Group and its work to prevent, recognize, and manage these toxicities. They highlight multicenter efforts spanning photosensitivity prevention, survivorship outcomes, and targeted therapy side effects—including MEK inhibitor–associated mucocutaneous toxicities—plus the need for stronger derm–onc collaboration, better trial reporting, and evidence-based consensus guidelines. Keywords: Skin Cancer, MEK Inhibitors, Consensus Guidelines, Photosensitivity
Blaschko-Linear TGM1-nEDD Associated With Mosaic Genome-Wide Uniparental Isodisomy
Luo, Angela, et al. American Journal of Medical Genetics Part A (2026).
How Young is too Young for Hormonal Acne Treatment?
In her final episode as guest host, PeDRA Fellow Hannah Chang talks with Dr. Andrea Zaenglein and Dr. Jonette…
Inside the Connective Tissue and Autoinflammatory Disorders Focused Study Group
In this episode, we bring together two leaders in pediatric dermatology research to explore the work of PeDRA’s Connective…
Minds Behind the Mission: How Two Researchers Are Improving Eczema Screening for Children with Neurodevelopmental and Complex Needs
April 16, 2026 – The first-of-its-kind exploratory study, Advancing Screening and Education for Eczema in Children with Neurodevelopmental and Complex…